Gazerani, P <br/><br/>
Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin.  [electronic resource] 

 -  The British journal of dermatology  Oct 2009 
 - 737-45 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1365-2133 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2133.2009.09305.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antipruritics--administration & dosage<br/>Botulinum Toxins, Type A--administration & dosage<br/>Dermatitis--drug therapy<br/>Double-Blind Method<br/>Histamine<br/>Humans<br/>Laser-Doppler Flowmetry<br/>Male<br/>Prospective Studies<br/>Pruritus--chemically induced<br/>Skin--blood supply<br/>Skin Tests<br/>Thermography<br/>Vasoconstriction--drug effects